Human medicines European public assessment report (EPAR): Volibris, ambrisentan, Date of authorisation: 20/04/2008, Revision: 24, Status: Authorised

Herbal medicinal product: Malvae foliumArray,Array, F: Assessment finalised

Human medicines European public assessment report (EPAR): Vafseo, vadadustat, Date of authorisation: 24/04/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Incellipan, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 19/04/2024, Status: Authorised

Handling competing interests

Human medicines European public assessment report (EPAR): Celldemic, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 19/04/2024, Status: Authorised

Human medicines European public assessment report (EPAR): Zynyz, retifanlimab, Date of authorisation: 19/04/2024, Status: Authorised

CAT quarterly highlights and approved ATMPs - February - April 2024

Quality of medicines questions and answers: Part 1